Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 4Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Leukemia 23Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Multiple Myeloma 17Lymphoma, Non-Hodgkin 17Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma, Follicular 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma 15Leukemia, Myeloid, Accelerated Phase 14Hodgkin Disease 14Blast Crisis 13Leukemia, Myelomonocytic, Chronic 12Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Myeloid, Chronic-Phase 11Burkitt Lymphoma 11Ovarian Neoplasms 10Myeloproliferative Disorders 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma, B-Cell, Marginal Zone 10Congenital Abnormalities 10Neoplasms, Plasma Cell 9Breast Neoplasms 9Waldenstrom Macroglobulinemia 7Polycythemia Vera 7Leukemia, Biphenotypic, Acute 7Thrombocythemia, Essential 6Primary Myelofibrosis 6Carcinoma, Ovarian Epithelial 6

Interventions

Rituximab 4Lenalidomide 2veliparib 1romidepsin 1liposomal doxorubicin 1fludarabine phosphate 1flt3 ligand protein 1ethanolamine oleate 1Whole-Body Irradiation 1Vincristine 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Thrombopoietin 1Sulfamethoxazole 1Stem Cell Factor 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Mycophenolic Acid 1Ipilimumab 1Filgrastim 1Etoposide 1Ethanol 1Edetic Acid 1Doxorubicin 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Intraocular Lymphoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00006251 2020-01-21

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
21 enrolled
DermatologicGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡